The Greater Poland Cancer Centre
13
3
4
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Subclinical Monitoring of Lymphatic Function in Oncology Patients for Lymphoedema Prevention (ONCOLYMPH)
Role: lead
Translational PKPD Modeling of Anti-infective Drugs Used in Pediatric Units.
Role: collaborator
Focal Salvage Brachytherapy Study (FocaSaBra)
Role: lead
Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy
Role: lead
Assessing the Implementation of Myofascial Techniques in Patients With Accessory Nerve Damage After Oncologic Treatment
Role: lead
HPV Serum Level and FDG PET CT in Patients With Cervical Cancer Treated With Radical Radiochemotherapy
Role: lead
High Five (HiFi) Accelerated Partial Breast Irradiation Study
Role: lead
The Cognitive-Behavioral Dysfunctions and the Potential of Neuroplasticity in Brain Tumors Patients During Radiotherapy
Role: lead
Pharmacotherapy Personalization of Cancer Patients
Role: collaborator
Myofascial Versus Conventional Physiotherapy
Role: lead
Comparing Hypofractionated Radiotherapy Boost to Conventionally Fractionated
Role: lead
Prospective Evaluation of Hypofractionated Stereotactic RT Using CyberKnife for Patients With Prostate Cancer
Role: lead
Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative Radiotherapy
Role: collaborator
All 13 trials loaded